A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia.


The current study explored whether oxytocin can improve social cognition and social skills in individuals with schizophrenia using a six-week, double-blind design. Fourteen participants with schizophrenia were randomized to receive either intranasal oxytocin or a placebo solution and completed a battery of social cognitive, social skills and clinical… (More)
DOI: 10.1016/j.schres.2014.04.009


4 Figures and Tables

Slides referencing similar topics